1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA GPRIN1 CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA FIZ1 CTRPv2 pan-cancer AAC 0.18 7e-08
mRNA FBRSL1 CTRPv2 pan-cancer AAC 0.19 8e-08
mRNA PIDD1 CTRPv2 pan-cancer AAC 0.18 8e-08
mRNA RP11-212D19.4 CTRPv2 pan-cancer AAC -0.18 8e-08
mRNA ZNF852 CTRPv2 pan-cancer AAC 0.2 8e-08
mRNA PAFAH1B3 CTRPv2 pan-cancer AAC 0.19 8e-08
mRNA MAST1 CTRPv2 pan-cancer AAC 0.19 9e-08
mRNA C20orf96 CTRPv2 pan-cancer AAC 0.18 9e-08
mRNA SAMD1 CTRPv2 pan-cancer AAC 0.19 9e-08
Download CSV